Giorgio Napodano

573 total citations
26 papers, 227 citations indexed

About

Giorgio Napodano is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Giorgio Napodano has authored 26 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Giorgio Napodano's work include Bladder and Urothelial Cancer Treatments (6 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Urological Disorders and Treatments (5 papers). Giorgio Napodano is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Urological Disorders and Treatments (5 papers). Giorgio Napodano collaborates with scholars based in Italy, Türkiye and France. Giorgio Napodano's co-authors include Vincenzo Altieri, Monica Cantile, Luca Cindolo, Clemente Cillo, R. Sanseverino, Felice Crocetto, Biagio Barone, Francesco Paolo Calace, Domenico Prezioso and Sertaç Yazıcı and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and The Journal of Urology.

In The Last Decade

Giorgio Napodano

26 papers receiving 222 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giorgio Napodano Italy 9 73 72 67 48 39 26 227
Dong Hyeon Lee South Korea 9 81 1.1× 52 0.7× 155 2.3× 35 0.7× 63 1.6× 30 273
Claudia E. Falkensammer Austria 8 54 0.7× 57 0.8× 44 0.7× 111 2.3× 14 0.4× 16 269
Gianfranco Mattarelli Switzerland 7 69 0.9× 106 1.5× 121 1.8× 34 0.7× 34 0.9× 10 272
Roni M. Cox United States 10 140 1.9× 191 2.7× 156 2.3× 41 0.9× 45 1.2× 21 323
Kensuke Bekku Japan 9 39 0.5× 114 1.6× 105 1.6× 41 0.9× 19 0.5× 57 221
Changping Men China 11 110 1.5× 100 1.4× 101 1.5× 32 0.7× 80 2.1× 27 317
Facundo Davaro United States 9 50 0.7× 76 1.1× 164 2.4× 30 0.6× 17 0.4× 35 238
Stephen Peyton United States 8 63 0.9× 30 0.4× 76 1.1× 34 0.7× 25 0.6× 10 227
Thomas Schnöller Germany 5 31 0.4× 45 0.6× 192 2.9× 50 1.0× 13 0.3× 10 275
Yong-zhong Mao China 12 42 0.6× 88 1.2× 311 4.6× 23 0.5× 29 0.7× 21 380

Countries citing papers authored by Giorgio Napodano

Since Specialization
Citations

This map shows the geographic impact of Giorgio Napodano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giorgio Napodano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giorgio Napodano more than expected).

Fields of papers citing papers by Giorgio Napodano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giorgio Napodano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giorgio Napodano. The network helps show where Giorgio Napodano may publish in the future.

Co-authorship network of co-authors of Giorgio Napodano

This figure shows the co-authorship network connecting the top 25 collaborators of Giorgio Napodano. A scholar is included among the top collaborators of Giorgio Napodano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giorgio Napodano. Giorgio Napodano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aveta, Achille, Giorgio Napodano, Gianluca Spena, et al.. (2025). Rare case of urinary tract infection caused by Cedecea lapagei in a 93-year-old patient in southern Italy. Infezioni in Medicina. 33(2). 221–225. 1 indexed citations
2.
3.
Yazıcı, Sertaç, Giorgio Napodano, Francesco Paolo Calace, et al.. (2023). Risk Factors for Testicular Cancer: Environment, Genes and Infections—Is It All?. Medicina. 59(4). 724–724. 28 indexed citations
5.
Napolitano, Luigi, Biagio Barone, Luigi De Luca, et al.. (2022). Preoperative monocyte-to-lymphocyte ratio as a potential predictor of bladder cancer. Journal of Basic and Clinical Physiology and Pharmacology. 33(6). 751–757. 5 indexed citations
6.
Barone, Biagio, Luigi Napolitano, Luigi Cirillo, et al.. (2022). Abnormal presentation of a bilateral, synchronous and plurimetastatic medium and large cell testicular lymphoma: A case report. Molecular and Clinical Oncology. 17(2). 124–124. 2 indexed citations
7.
Tamburrini, Stefania, Marina Lugarà, Giorgio Napodano, et al.. (2021). Nephrobronchial fistula a case report and review of the literature. SHILAP Revista de lepidopterología. 16(11). 3470–3477. 6 indexed citations
8.
Tamburrini, Stefania, et al.. (2021). Skene's glands abscess an overlooked diagnosis in acute lower urinary symptoms. SHILAP Revista de lepidopterología. 16(12). 3751–3756. 3 indexed citations
9.
Brassetti, Aldo, Mariaconsiglia Ferriero, Giorgio Napodano, et al.. (2021). Physical activity decreases the risk of cancer reclassification in patients on active surveillance: a multicenter retrospective study. Prostate Cancer and Prostatic Diseases. 24(4). 1151–1157. 10 indexed citations
10.
Sanseverino, R., et al.. (2021). ‘Burned‑out’ syndrome of testicular teratoma: A case report. Molecular and Clinical Oncology. 15(6). 262–262. 1 indexed citations
11.
Lorenzo, Giuseppe Di, Concetta Ingenito, Felice Crocetto, et al.. (2020). Clinical Characteristics of Metastatic Prostate Cancer Patients Infected with COVID-19 in South Italy. Oncology. 98(10). 743–747. 29 indexed citations
12.
Addesso, Maria, Alessandro Caputo, Antonio D’Antonio, Giorgio Napodano, & R. Sanseverino. (2020). A Large Paraprostatic Mass in A Man: Rare Presentation of Aggressive Angiomyxoma. Urology. 143. e3–e4. 4 indexed citations
13.
Sanseverino, R., et al.. (2016). Prognostic impact of ReTURB in high grade T1 primary bladder cancer. Archivio Italiano di Urologia e Andrologia. 88(2). 81–81. 7 indexed citations
14.
Bertaccini, Alessandro, R. Sanseverino, Giorgio Napodano, et al.. (2012). Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.. PubMed. 84(3). 117–22. 11 indexed citations
15.
Ferro, M., Daniela Terracciano, Alfonso Mariño, et al.. (2011). Prostate health index (PHI) is able to discriminate benign and precancerous conditions from prostate cancer. 31. 1916–1917. 1 indexed citations
16.
Lorenzo, Giuseppe Di, Riccardo Autorino, Antonio Giordano, et al.. (2007). Phase II Trial of Gemcitabine, Prednisone, and Zoledronic Acid in Pretreated Patients with Hormone Refractory Prostate Cancer. Urology. 69(2). 347–351. 12 indexed citations
17.
Sanseverino, R., et al.. (2007). V3 YORK MASON TRANS-SPHYNTERIC TRANS-RECTAL REPAIR OF IATROGENIC RECTO-URINARY FISTULA: CASE REPORT. European Urology Supplements. 6(2). 293–293. 1 indexed citations
18.
Mascolo, Massimo, Vincenzo Altieri, Chiara Mignogna, et al.. (2005). Calcitonin-producing well-differentiated neuroendocrine carcinoma (carcinoid tumor) of the urinary bladder: case report. BMC Cancer. 5(1). 88–88. 13 indexed citations
19.
Cantile, Monica, Luca Cindolo, Giorgio Napodano, Vincenzo Altieri, & Clemente Cillo. (2003). Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas. Oncogene. 22(41). 6462–6468. 55 indexed citations
20.
Cindolo, Luca, et al.. (2001). Not traditional prognostic factors in human conventional renal carcinoma.. PubMed. 53(4). 211–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026